+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 1bj1 | ||||||
---|---|---|---|---|---|---|---|
タイトル | VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY | ||||||
![]() |
| ||||||
![]() | IMMUNE SYSTEM / COMPLEX (ANTIBODY-ANTIGEN) / ANGIOGENIC FACTOR | ||||||
機能・相同性 | ![]() basophil chemotaxis / positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway / cellular stress response to acid chemical / VEGF-A complex / Signaling by VEGF / lymph vessel morphogenesis / positive regulation of lymphangiogenesis / negative regulation of adherens junction organization / vascular endothelial growth factor receptor 1 binding / negative regulation of establishment of endothelial barrier ...basophil chemotaxis / positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway / cellular stress response to acid chemical / VEGF-A complex / Signaling by VEGF / lymph vessel morphogenesis / positive regulation of lymphangiogenesis / negative regulation of adherens junction organization / vascular endothelial growth factor receptor 1 binding / negative regulation of establishment of endothelial barrier / vascular endothelial growth factor receptor binding / VEGF ligand-receptor interactions / positive regulation of mast cell chemotaxis / post-embryonic camera-type eye development / primitive erythrocyte differentiation / positive regulation of protein kinase C signaling / positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway / negative regulation of blood-brain barrier permeability / VEGF-activated neuropilin signaling pathway / bone trabecula formation / positive regulation of vascular endothelial growth factor signaling pathway / coronary vein morphogenesis / cardiac vascular smooth muscle cell development / lung vasculature development / lymphangiogenesis / eye photoreceptor cell development / endothelial cell chemotaxis / motor neuron migration / positive regulation of trophoblast cell migration / positive regulation of epithelial tube formation / vascular endothelial growth factor receptor-2 signaling pathway / VEGF binds to VEGFR leading to receptor dimerization / regulation of nitric oxide mediated signal transduction / positive regulation of axon extension involved in axon guidance / vascular wound healing / positive regulation of protein localization to early endosome / regulation of hematopoietic progenitor cell differentiation / positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis / positive regulation of branching involved in ureteric bud morphogenesis / camera-type eye morphogenesis / neuropilin binding / induction of positive chemotaxis / coronary artery morphogenesis / negative regulation of cell-cell adhesion mediated by cadherin / vascular endothelial growth factor receptor 2 binding / tube formation / positive regulation of vascular permeability / dopaminergic neuron differentiation / commissural neuron axon guidance / negative regulation of epithelial to mesenchymal transition / platelet-derived growth factor receptor binding / surfactant homeostasis / extracellular matrix binding / cell migration involved in sprouting angiogenesis / cardiac muscle cell development / epithelial cell maturation / sprouting angiogenesis / positive regulation of positive chemotaxis / endothelial cell proliferation / Regulation of gene expression by Hypoxia-inducible Factor / positive regulation of leukocyte migration / vascular endothelial growth factor signaling pathway / positive regulation of p38MAPK cascade / positive regulation of endothelial cell chemotaxis / artery morphogenesis / branching involved in blood vessel morphogenesis / positive regulation of cell migration involved in sprouting angiogenesis / positive regulation of DNA biosynthetic process / retinal ganglion cell axon guidance / positive regulation of neuroblast proliferation / positive chemotaxis / negative regulation of fat cell differentiation / transmembrane receptor protein tyrosine kinase activator activity / positive regulation of sprouting angiogenesis / chemoattractant activity / outflow tract morphogenesis / positive regulation of focal adhesion assembly / mesoderm development / monocyte differentiation / positive regulation of receptor internalization / macrophage differentiation / fibronectin binding / positive regulation of cell division / positive regulation of cell adhesion / neuroblast proliferation / positive regulation of blood vessel endothelial cell migration / cellular response to vascular endothelial growth factor stimulus / mammary gland alveolus development / vasculogenesis / positive regulation of osteoblast differentiation / vascular endothelial growth factor receptor signaling pathway / heart morphogenesis / ovarian follicle development / cell maturation / homeostasis of number of cells within a tissue / positive regulation of protein autophosphorylation / positive regulation of endothelial cell proliferation / epithelial cell differentiation / lactation / TFAP2 (AP-2) family regulates transcription of growth factors and their receptors 類似検索 - 分子機能 | ||||||
生物種 | ![]() ![]() ![]() | ||||||
手法 | ![]() ![]() ![]() | ||||||
![]() | Muller, Y.A. / Christinger, H.W. / De Vos, A.M. | ||||||
![]() | ![]() タイトル: VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface. 著者: Muller, Y.A. / Chen, Y. / Christinger, H.W. / Li, B. / Cunningham, B.C. / Lowman, H.B. / de Vos, A.M. #1: ![]() タイトル: Antibody Humanization Using Monovalent Phage Display 著者: Baca, M. / Presta, L.G. / O'Connor, S.J. / Wells, J.A. #2: ![]() タイトル: Humanization of an Anti-Vascular Endothelial Growth Factor Monoclonal Antibody for the Therapy of Solid Tumors and Other Disorders 著者: Presta, L.G. / Chen, H. / O'Connor, S.J. / Chisholm, V. / Meng, Y.G. / Krummen, L. / Winkler, M. / Ferrara, N. | ||||||
履歴 |
|
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 223.8 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 181.3 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
文書・要旨 | ![]() | 484 KB | 表示 | ![]() |
---|---|---|---|---|
文書・詳細版 | ![]() | 511.3 KB | 表示 | |
XML形式データ | ![]() | 45.2 KB | 表示 | |
CIF形式データ | ![]() | 65.5 KB | 表示 | |
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
-関連構造データ
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||||||||||||||||||||||||||||||||||||
単位格子 |
| ||||||||||||||||||||||||||||||||||||||||||
非結晶学的対称性 (NCS) | NCSドメイン:
NCS oper:
|
-
要素
#1: 抗体 | 分子量: 23471.949 Da / 分子数: 2 / 由来タイプ: 組換発現 詳細: HUMANIZED VERSION OF A MONOCLONAL MURINE ANTI-VEGF ANTIBODY 由来: (組換発現) ![]() ![]() 解説: HUMANIZED VERSION OF A MONOCLONAL MURINE ANTI-VEGF ANTIBODY 発現宿主: ![]() ![]() #2: 抗体 | 分子量: 24890.764 Da / 分子数: 2 / 由来タイプ: 組換発現 詳細: HUMANIZED VERSION OF A MONOCLONAL MURINE ANTI-VEGF ANTIBODY 由来: (組換発現) ![]() ![]() 解説: HUMANIZED VERSION OF A MONOCLONAL MURINE ANTI-VEGF ANTIBODY 発現宿主: ![]() ![]() #3: タンパク質 | 分子量: 11948.680 Da / 分子数: 2 / Fragment: RECEPTOR BINDING DOMAIN / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() ![]() ![]() #4: 化合物 | #5: 水 | ChemComp-HOH / | 配列の詳細 | THE NUMBERING OF THE LIGHT CHAINS L AND J AS WELL AS OF THE HEAVY CHAINS H AND K IS SEQUENTIAL. ...THE NUMBERING OF THE LIGHT CHAINS L AND J AS WELL AS OF THE HEAVY CHAINS H AND K IS SEQUENTIAL | |
---|
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 3.6 Å3/Da / 溶媒含有率: 66 % | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
結晶化 | pH: 6 / 詳細: pH 6.0 | ||||||||||||||||||||||||||||||||||||||||
結晶化 | *PLUS 手法: 蒸気拡散法, シッティングドロップ法詳細: drop solution was mixed with an equal volume of reservoir solution | ||||||||||||||||||||||||||||||||||||||||
溶液の組成 | *PLUS
|
-データ収集
回折 | 平均測定温度: 100 K |
---|---|
放射光源 | 由来: ![]() ![]() ![]() |
検出器 | タイプ: ADSC QUANTUM / 検出器: CCD / 日付: 1996年3月1日 |
放射 | 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 0.914 Å / 相対比: 1 |
反射 | 解像度: 2.4→20 Å / Num. obs: 63147 / % possible obs: 96 % / 冗長度: 3.8 % / Rmerge(I) obs: 0.071 / Net I/σ(I): 8.6 |
反射 シェル | 解像度: 2.4→2.48 Å / Rmerge(I) obs: 0.128 / Mean I/σ(I) obs: 3.5 / % possible all: 81.3 |
反射 シェル | *PLUS % possible obs: 81.3 % |
-
解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: ![]() 開始モデル: PDB ENTRY 2VPF AND 1FVD 解像度: 2.4→8 Å / Rfactor Rfree error: 0.0035 / Data cutoff high absF: 100000 / Data cutoff low absF: 0.1 / Isotropic thermal model: RESTRAINED / 交差検証法: THROUGHOUT / σ(F): 0 詳細: THE MODEL IS UNUSUAL IN REGARD TO THE HIGH AVERAGE TEMPERATURE FACTOR OF 100 A2 OF THE CONSTANT DOMAIN OF THE SECOND FAB MOLECULE. HOWEVER THE USE OF NON-CRYSTALLOGRAPHIC SYMMETRY RESTRAINTS ...詳細: THE MODEL IS UNUSUAL IN REGARD TO THE HIGH AVERAGE TEMPERATURE FACTOR OF 100 A2 OF THE CONSTANT DOMAIN OF THE SECOND FAB MOLECULE. HOWEVER THE USE OF NON-CRYSTALLOGRAPHIC SYMMETRY RESTRAINTS GREATLY RESTRICTS THE CONFORMATIONAL FREEDOM OF THIS PORTION TO THE WELL-DEFINED CONSTANT DOMAIN OF THE FIRST FAB FRAGMENT. MORE DETAILS CAN BE FOUND IN THE PRIMARY PUBLICATION.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | Biso mean: 42 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refine analyze | Luzzati sigma a obs: 0.35 Å | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 2.4→8 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refine LS restraints NCS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LS精密化 シェル | 解像度: 2.4→2.48 Å / Rfactor Rfree error: 0.017 / Total num. of bins used: 10
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Xplor file |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ソフトウェア | *PLUS 名称: ![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化 | *PLUS Num. reflection obs: 54493 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 | *PLUS
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LS精密化 シェル | *PLUS Rfactor obs: 0.312 |